🇺🇸 FDA
Patent

US 6492426

Use of 1-aminoindan derivatives for treatment of mania in bipolar mood disorder

expired A61KA61K31/16A61K31/165

Quick answer

US patent 6492426 (Use of 1-aminoindan derivatives for treatment of mania in bipolar mood disorder) held by TEVA PHARMACEUTICAL INDUSTRIES, LTD. expires Mon Dec 05 2022 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
TEVA PHARMACEUTICAL INDUSTRIES, LTD.
Grant date
Tue Dec 10 2002 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 05 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/16, A61K31/165, A61K31/166, A61P